Member Exclusive
News
How inhibiting one protein could provide the key in the treatment of Parkinson’s disease
Researchers from Georgetown University Medical Center (DC, USA) have found the protein – USP13 – removes all the tags on the protein alpha-synuclein which would normally mark them for destruction and leads to accumulation of the protein in a cluster which has toxic effects in the brain.
Please sign in or register for FREE
Sign in to RxNet
Not yet a member? Become a member FREE to:
- Get unlimited access to ALL CONTENT
- Read selected articles from journals such as Future Medicinal Chemistry FREE
- Receive a weekly email roundup of the latest news and expert opinions
- Connect and collaborate with other members
- Post about your own research, share your take on key topics and more
No comments yet.